Optimi Health is trading at $1.97 (-6.64%); the reason for the November 4 decline remains unclear, with no company-specific catalyst identified.

  • No fresh company-specific announcement surfaced, and coverage reports no headlines for the date.
  • The decline runs counter to the supplied positive biotech and broad-market context, which does not explain the move.
  • The stock also fell in preceding sessions, but that pattern alone does not establish a cause.